Filter News
Area of Research
- (-) Neutron Science (11)
- (-) Supercomputing (19)
- Biological Systems (1)
- Biology and Environment (18)
- Clean Energy (16)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (1)
- Isotopes (5)
- Materials (24)
- Materials for Computing (7)
- National Security (2)
- Nuclear Science and Technology (2)
News Topics
- (-) Biomedical (25)
- (-) Polymers (3)
- 3-D Printing/Advanced Manufacturing (10)
- Advanced Reactors (2)
- Artificial Intelligence (39)
- Big Data (20)
- Bioenergy (13)
- Biology (14)
- Biotechnology (2)
- Buildings (4)
- Chemical Sciences (6)
- Clean Water (2)
- Climate Change (17)
- Composites (1)
- Computer Science (98)
- Coronavirus (17)
- Critical Materials (3)
- Cybersecurity (9)
- Decarbonization (7)
- Energy Storage (14)
- Environment (28)
- Exascale Computing (22)
- Fossil Energy (1)
- Frontier (29)
- Fusion (2)
- Grid (5)
- High-Performance Computing (39)
- Isotopes (1)
- Machine Learning (16)
- Materials (28)
- Materials Science (33)
- Mathematics (1)
- Microscopy (8)
- Molten Salt (1)
- Nanotechnology (19)
- National Security (8)
- Net Zero (1)
- Neutron Science (101)
- Nuclear Energy (7)
- Partnerships (1)
- Physics (16)
- Quantum Computing (19)
- Quantum Science (29)
- Security (6)
- Simulation (14)
- Software (1)
- Space Exploration (5)
- Summit (42)
- Sustainable Energy (11)
- Transportation (10)
Media Contacts
![A small droplet of water is suspended in midair via an electrostatic levitator that lifts charged particles using an electric field that counteracts gravity. Credit: Iowa State University/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2023-11/droplet.png?h=ddb1ad0c&itok=3nblnUcm)
How do you get water to float in midair? With a WAND2, of course. But it’s hardly magic. In fact, it’s a scientific device used by scientists to study matter.
![ORNL scientists developed a method that improves the accuracy of the CRISPR Cas9 gene editing tool used to modify microbes for renewable fuels and chemicals production. This research draws on the lab’s expertise in quantum biology, artificial intelligence and synthetic biology. Credit: Philip Gray/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2023-11/CRISPR%20Quantum%20AI_2_23-G07105-DOE-BER-BESSD-comms-graphic-pcg_2.jpg?h=847b7ff0&itok=WD2dBsAC)
Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.
![Hilda Klasky](/sites/default/files/styles/list_page_thumbnail/public/2023-11/Hilda%20Klasky.jpg?h=dbae05b8&itok=CPlpl2-D)
Hilda Klasky, an R&D staff member in the Scalable Biomedical Modeling group at ORNL, has been selected as a senior member of the Association of Computing Machinery, or ACM.
![MDF Exterior](/sites/default/files/styles/list_page_thumbnail/public/2022-06/2021-p07609.jpg?h=be3e4b3a&itok=YfKK7Wy2)
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
![ORNL, VA and Harvard researchers developed a sparse matrix full of anonymized information on what is thought to be the largest cohort of healthcare data used for this type of research in the U.S. The matrix can be probed with different methods, such as KESER, to gain new insights into human health. Credit: Nathan Armistead/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-04/2022-G00330_KESER%20Illustration_0.jpg?h=1cb48fc4&itok=c6ZuDdDg)
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
![Genetic analysis revealed connections between inflammatory activity and development of atomic dermatitis, according to researchers from the UPenn School of Medicine, the Perelman School of Medicine, and Oak Ridge National Laboratory. Credit: Kang Ko/UPenn](/sites/default/files/styles/list_page_thumbnail/public/2022-02/Graves-AD_0.jpg?h=46d8a70d&itok=77AW7Swv)
University of Pennsylvania researchers called on computational systems biology expertise at Oak Ridge National Laboratory to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
![An ORNL-led team studied the SARS-CoV-2 spike protein in the trimer state, shown here, to pinpoint structural transitions that could be disrupted to destabilize the protein and negate its harmful effects. Credit: Debsindhu Bhowmik/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-01/sars_cov_2_bk.png?h=05c2797f&itok=jQ2D9aTr)
To explore the inner workings of severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, researchers from ORNL developed a novel technique.
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
![Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/after_transprent_background-wFill.png?h=c71d0c67&itok=jGFt_Ggj)
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
![Frontier supercomputer](/sites/default/files/styles/list_page_thumbnail/public/2023-01/frontier_0.jpg?h=a1e1a043&itok=J3IM_Xeh)
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.